" /> Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A - CISMeF





Preferred Label : Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A;

NCIt synonyms : Anti-CD228 Antibody-drug Conjugate SGN-CD228A; Anti-CD228/MMAE ADC SGN-CD228A; Anti-CD228-MMAE ADC SGN-CD228A; Anti-melanotransferrin ADC SGN-CD228A;

NCIt definition : An antibody-drug conjugate (ADC) composed of a humanized antibody targeting the cell surface antigen cluster of differentiation (CD228; melanotransferrin; MFI2; MELTF) that is conjugated, via a beta-glucuronidase-cleavable linker, to the microtubule-disrupting cytotoxic agent monomethyl auristatin E (MMAE), with potential antineoplastic activity. Following administration, the antibody moiety of anti-CD228/MMAE ADC SGN-CD228A targets and binds to CD228 on the surface of tumor cells. Following internalization of SGN-CD228A and release of MMAE, MMAE targets and binds to tubulin, and inhibits microtubule polymerization. This results in G2/M phase cell cycle arrest and apoptosis in CD228-expressing tumor cells. CD228, a cell-surfaced, glycosylphosphatidylinoitol (GPI)-anchored glycoprotein, belongs to the transferrin family of iron-binding proteins.;

Molecule name : SGN CD228A; SGN-CD228A;

NCI Metathesaurus CUI : CL1378671;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.